Capital Fund Management (CFM)
IMVT icon

Capital Fund Management (CFM)’s Immunovant IMVT Stock Holding History

Capital Fund Management (CFM)’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
+51,448
New +$1.57M 0.01% 1432
2025
Q4 		– Sell
-35,128
Closed -$566K – 2500
2025
Q3 		$566K Sell
35,128
-20,396
-37% -$330K ﹤0.01% 2273
2025
Q2 		$888K Buy
+55,524
New +$840K ﹤0.01% 2045

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Fund Management (CFM)'s IMVT Position: Q2 2026 in Review

Capital Fund Management (CFM) opened a new position in Immunovant (IMVT) in Q2 2026: 51,448 shares worth $1.98M. The stake represents 0.01% of the portfolio and ranks #1432 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in IMVT as recently as Q3 2025.

Capital Fund Management (CFM) first reported a position in IMVT in Q2 2025 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Capital Fund Management (CFM) held 51,448 shares of Immunovant worth $1.98M as of Q2 2026.
  • Immunovant was a new Capital Fund Management (CFM) position in Q2 2026.
  • Immunovant made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1432 holding.
  • Capital Fund Management (CFM) first reported a position in Immunovant in Q2 2025 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.